CATALIO CAPITAL MANAGEMENT, LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | GUTS | 5.21M | $8.29M |
 | SNDX | 1.61M | $24.84M |
 | TARA | 1.50M | $6.53M |
 | PHAT | 1.13M | $13.28M |
 | ELDN | 1.06M | $2.75M |
 | ADPT | 885K | $13.24M |
 | HYPR | 685K | $992.58K |
 | ADMA | 685K | $10.03M |
 | DNTH | 668K | $26.27M |
 | GPCR | 652K | $18.25M |
 | BBIO | 623K | $32.34M |
 | KYTX | 587K | $3.52M |
 | MGX | 529K | $1.25M |
 | CYTK | 452K | $24.82M |
 | SLNO | 418K | $28.27M |
 | SEPN | 294K | $5.54M |
 | RARE | 291K | $8.76M |
 | SUPN | 287K | $13.72M |
 | QURE | 283K | $16.52M |
 | RNA | 263K | $11.47M |
Fractyl Health, Inc. Common Stock
GUTS
Shares Held
5.21M
Value
$8.29M
Syndax Pharmaceuticals, Inc.
SNDX
Shares Held
1.61M
Value
$24.84M
Protara Therapeutics, Inc.
TARA
Shares Held
1.50M
Value
$6.53M
Phathom Pharmaceuticals, Inc.
PHAT
Shares Held
1.13M
Value
$13.28M
Eledon Pharmaceuticals, Inc.
ELDN
Shares Held
1.06M
Value
$2.75M
Adaptive Biotechnologies Corporation
ADPT
Shares Held
885K
Value
$13.24M
Hyperfine, Inc.
HYPR
Shares Held
685K
Value
$992.58K
ADMA Biologics, Inc.
ADMA
Shares Held
685K
Value
$10.03M
Dianthus Therapeutics, Inc.
DNTH
Shares Held
668K
Value
$26.27M
Structure Therapeutics Inc.
GPCR
Shares Held
652K
Value
$18.25M
BridgeBio Pharma, Inc.
BBIO
Shares Held
623K
Value
$32.34M
Kyverna Therapeutics, Inc.
KYTX
Shares Held
587K
Value
$3.52M
Metagenomi, Inc. Common Stock
MGX
Shares Held
529K
Value
$1.25M
Cytokinetics, Incorporated
CYTK
Shares Held
452K
Value
$24.82M
Soleno Therapeutics, Inc.
SLNO
Shares Held
418K
Value
$28.27M
Septerna, Inc.
SEPN
Shares Held
294K
Value
$5.54M
Ultragenyx Pharmaceutical Inc.
RARE
Shares Held
291K
Value
$8.76M
Supernus Pharmaceuticals, Inc.
SUPN
Shares Held
287K
Value
$13.72M
uniQure N.V.
QURE
Shares Held
283K
Value
$16.52M
Avidity Biosciences, Inc.
RNA
Shares Held
263K
Value
$11.47M